On track for top-line data in April 2022 WARRINGTON, Pa., March 15, 2022 (GLOBE NEWSWIRE) — Windtree Therapeutics, Inc. (NasdaqCM: WINT), a biotechnology company focused on advancing multiple late-stage interventions for acute cardiovascular and pulmonary disorders, today announced it has successfully completed enrollment in its phase 2 study of istaroxime […]
Other News
Nuwellis Announces IRB Approval to Begin Its REVERSE-HF Clinical Study
The REVERSE-HF study will evaluate ultrafiltration therapy for heart failure patients suffering from fluid overload MINNEAPOLIS, March 15, 2022 (GLOBE NEWSWIRE) — Nuwellis, Inc. (Nasdaq: NUWE) today announced it has received independent Institutional Review Board (IRB) approval for the trial protocol of the company’s REVERSE-HF (Ultrafiltration Versus IV Diuretics in Worsening Heart Failure) clinical study […]
Fujifilm Presents Award-winning Synapse Enterprise Imaging Portfolio at HIMSS 2022
The Company celebrated its recognition for three Synapse solutions at KLAS Research’s 2022 Best In KLAS® Show Lexington, Mass., March 15, 2022 (GLOBE NEWSWIRE) — March 15, 2022 – Booth 3947 – FUJIFILM Healthcare Americas Corporation, a leading provider of enterprise imaging and informatics solutions, is showcasing its award-winning Synapse Enterprise Imaging portfolio […]
LimFlow Completes Enrollment in PROMISE II U.S. Pivotal Trial of Breakthrough Device Designed to Prevent Amputations in No-Option Patients With Chronic Limb-Threatening Ischemia
PARIS–(BUSINESS WIRE)–LimFlow SA, a pioneer in the development of minimally-invasive technology for the treatment of chronic limb-threatening ischemia (CLTI), a severe form of peripheral artery disease (PAD), announced today that it has completed patient enrollment in the PROMISE II pivotal trial of the LimFlow System. The LimFlow System is designed […]
Fist Assist Devices, LLC Announces Australian Distribution Deal and Sales Launch
Regional Health Care Group Selected For Commercialization in Australian Market. LAS VEGAS–(BUSINESS WIRE)–Fist Assist Devices, LLC, announces a three-year affiliation with Regional Health Care Group to commercialize and launch sales of the Fist Assist Model FA-1 device in Australia and New Zealand. The Fist Assist Model FA-1 is a wearable, […]
Evidation, VA Collaborate to Enroll Veterans in Personalized Heart Health Program
App-based program was co-developed by Evidation and the American College of Cardiology WASHINGTON & SAN MATEO, Calif.–(BUSINESS WIRE)–Evidation and the Department of Veterans Affairs and the Veterans Health Administration Innovation Ecosystem (VHAIE) announced today an initiative to enroll Veterans in Heart Health on Evidation—a specialized heart health program built on […]
The Vascular Care Group Welcomes Nationally Recognized Vein Expert Dr. Harold J. Welch
Decorated physician brings 30+ years of experience to patients on Cape Cod HYANNIS, Mass.–(BUSINESS WIRE)–The Vascular Care Group (TVCG), a state-of-the art practice committed to the prevention, diagnosis and treatment of vascular disease, is pleased to announce that Harold J. Welch, MD, FACS, RVT, RPVI has recently joined the Hyannis, […]
iRhythm® Technologies Announces Kevin King to Retire from Board of Directors
SAN FRANCISCO, March 14, 2022 (GLOBE NEWSWIRE) — iRhythm Technologies, Inc. (NASDAQ: IRTC) (“iRhythm”), a leading digital healthcare solutions company focused on the advancement of cardiac care, today announced that Kevin King will retire from iRhythm’s Board of Directors effective April 1, 2022. Mr. King joined the iRhythm Board in […]
Philips introduces new cloud-enabled enterprise imaging informatics and analytics solutions at HIMSS22
Philips advances precision care with new releases of HealthSuite Interoperability and Enterprise Performance Analytics – PerformanceBridge Amsterdam, the Netherlands and Orlando, Florida, USA – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced its latest introductions in analytics and interoperability solutions at the HIMSS22 Global Health Conference […]
NeoChord Appoints Martin B. Leon, M.D. as Executive Chair of the U.S. Early Feasibility Study of the NeoChord Transcatheter NeXuS System
ST. LOUIS PARK, Minn., March 14, 2022 (GLOBE NEWSWIRE) — NeoChord, Inc., a privately-held medical technology company leading the advancement of beating heart mitral valve repair in patients suffering from mitral valve regurgitation, today announced the appointment of Martin B. Leon, M.D. as Executive Chair of the U.S. early feasibility study […]



